Lactulose and Mounjaro: can you take them together?

You've started Mounjaro and your digestion has changed — a familiar situation

It tends to happen a week or two in. Your appetite has shifted, you're eating less, and then you notice things have slowed down considerably in the bowel department. Constipation is one of the most consistently reported side effects of tirzepatide, listed clearly in the NHS patient information on tirzepatide. The mechanism isn't mysterious: Mounjaro activates GIP and GLP-1 receptors that, among other effects, slow the rate at which the stomach empties into the small intestine. Less food moving through the gut more slowly means the colon has less to work with, and transit time stretches. The result, for many people, is constipation that wasn't there before treatment started.

At this point some people reach for whatever is in the medicine cabinet. Others ask their pharmacist. A reasonable number search for whether lactulose specifically is safe to use. The question is a sensible one, and the short answer is that lactulose is generally considered compatible with Mounjaro, but let's look at why, and what to keep in mind. If you're also dealing with bloating, cramping or unpredictable bowel habits, the relationship between Mounjaro and IBS-type symptoms is worth reading alongside this page.

Why lactulose sits differently from some other laxatives when you're on Mounjaro

Lactulose works in the colon. It is a synthetic disaccharide that the small intestine cannot absorb or break down; it passes through largely intact until colonic bacteria ferment it, producing an osmotic effect that draws water into the bowel and softens stool. Because it acts locally and is not meaningfully absorbed into the systemic circulation, it does not interact with tirzepatide through the usual pharmacokinetic routes, it doesn't compete for the same enzymes or affect how Mounjaro is absorbed from the injection site.

There is one practical point worth noting, though. Mounjaro slows gastric emptying, which means that anything you swallow spends longer in the upper gut before reaching the small intestine and colon. For lactulose this is unlikely to cause a clinical problem, but it can mean the onset of its effect takes longer than usual. Some people find they need a little patience rather than a higher dose. It also means that if you take lactulose alongside other oral medicines, spacing them out sensibly matters, your prescriber can advise on that. For broader context on how tirzepatide interacts with other medicines, the GLP-1 interaction page covers the general picture, including questions about combining mazdutide and tirzepatide together. A full overview of the treatment itself is available on our Mounjaro information page.

A misconception worth clearing up gently

A common belief is that taking a laxative while on a weight-loss medicine will somehow enhance or speed up results. It won't. Lactulose addresses constipation (a genuine comfort issue) not fat loss. The weight reduction from tirzepatide comes from changes in appetite signalling and energy intake over weeks and months, not from bowel transit. In the SURMOUNT-1 trial, the average weight loss at 15mg over 72 weeks was in the region of 20–21%, and none of that was laxative-assisted. Using lactulose appropriately, for its intended purpose, is sensible self-care during treatment. Using it in the hope of a shortcut is neither necessary nor effective.

It is also worth saying that constipation can sometimes be managed without medication at all, at least initially. Adequate fluid intake, gentle movement, and enough fibre in a reduced-calorie diet can make a real difference. Our tirzepatide clinical guide covers practical lifestyle adjustments alongside treatment. If symptoms are severe or persistent, that is a conversation for your prescriber rather than a dose escalation of the laxative.

When to check with your prescriber rather than just getting on with it

For most people on Mounjaro without complicating factors, using lactulose occasionally for constipation is straightforward. There are situations, though, where you should ask before starting. If you have galactosaemia, lactulose is contraindicated regardless of what else you take. If you are on other regular oral medicines (particularly those with narrow therapeutic windows) slowed gastric emptying means your prescriber may want to think through timing. If constipation is severe, accompanied by abdominal pain, or persists beyond a couple of weeks despite simple measures, it warrants a clinical review; very occasionally constipation on a GLP-1 medicine signals something that needs investigating.

Mounjaro carries a Black Triangle (▼) designation, meaning the MHRA continues to collect data on it as a newer medicine. Reporting any side effects, including bowel symptoms that concern you, through the MHRA Yellow Card scheme contributes to that ongoing safety picture. If you're thinking about starting Mounjaro and want to understand the full side-effect profile before committing, our prescribers go through this in the consultation. The HRT and Mounjaro page and information on managing illness during treatment cover other practical real-world questions in a similar vein. For a sense of what private Mounjaro treatment involves cost-wise, that page sets out the context honestly. When you're ready to take the next step, start your free consultation and a GPhC-registered prescriber will review your full situation the same day.